Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); 2H Looks Bright

August 2, 2012 10:13 AM EDT
Get Alerts STAA Hot Sheet
Price: $23.45 +1.65%

Rating Summary:
    4 Buy, 11 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on STAAR Surgical (NASDAQ: STAA) price target of $8.25 (from $10.50).

Analyst, Jason R. Mills, said, "Q2 revenue of $15.9M was in line with preannounced results. GM was 69.3% vs. our 70.6%E. OpEx, ex mfg consolidation expense, was a tad higher than expected. That said, we believe several factors are in place for a solid H2 – including solid ICL sales in July, stronger US military ICL sales prospects, global ICL awareness campaigns, and the launch of two new IOL products. In addition, we’re encouraged that management moderated its F2012 expectations, which we think is both prudent and achievable. Our forward estimates, which were already more conservative than guidance, are unchanged."

For an analyst ratings summary and ratings history on STAAR Surgical click here. For more ratings news on STAAR Surgical click here.

Shares of STAAR Surgical closed at $5.14 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity